Document is current
Any future updates will be listed below
-
Authors
Belda, Eugeni
Capeau, Jacqueline
Zucker, Jean-Daniel
Chatelier, Emmanuelle Le
Pons, Nicolas
Oñate, Florian Plaza
Quinquis, Benoit
Alili, Rohia
Fellahi, Soraya
Katlama, Christine
Clément, Karine
Fève, Bruno
Jaureguiberry, Stéphane
Goujard, Cécile
Lambotte, Olivier
Doré, Joël
Prifti, Edi
Bastard, Jean-Philippe
-
Funding
Funding for this research was provided by:
Agence Nationale de Recherches sur le Sida et les Hépatites Virales (ANRS 157 study trial)
- License Information
-
More Information
Article History
Received: 10 April 2024
Accepted: 1 August 2024
First Online: 13 August 2024
Declarations
:
: ROCnRAL ANRS-157 study trial was approved by ANRS and CPP Ile de France VI (ANRS 157 study trial). All patients gave their informed consent to the protocol.
: Not applicable.
: The authors declare no competing interests.
: The Institutional Review Board of Pitié-Salpêtrière Hospital approved the study protocol (ClinicalTrials.gov: NCT01420523, first trial registration: 18/08/2011). The reference protocol (EudraCT 2011-002483-24 protocol 3.0 16/01/2012) and the amendment for the microbiote study were approved 29/02/2012 by AFSSAPS (Agence Française de Securité Sanitaire des produits de Santé) and DEMEB (Département de l’évaluation des essais cliniques et des médicaments à statut particulier). All patients provided written informed consent.
